Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,24,1.01 [0.98-1.04],0.562837067892398
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,24,0.81 [0.53-1.23],0.32567167274192
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,24,1.00 [0.95-1.06],0.897157943988797
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,24,1.39 [0.93-2.08],0.113360682419264
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,24,1.07 [1.01-1.13],0.0190303815512842
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",Inverse variance weighted,24,1.02 [0.86-1.20],0.854215481572282
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,Inverse variance weighted,24,0.93 [0.78-1.09],0.353153606271553
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,24,0.97 [0.73-1.29],0.831564393659822
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,Inverse variance weighted,24,0.91 [0.76-1.09],0.287253926067276
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,Inverse variance weighted,24,1.01 [0.83-1.23],0.893412880327753
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,Inverse variance weighted,24,0.99 [0.92-1.07],0.767057658295584
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,24,1.00 [0.93-1.07],0.995628993253687
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,24,0.94 [0.82-1.07],0.335586531581686
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,24,1.06 [0.90-1.25],0.502954705753684
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,Inverse variance weighted,24,1.02 [0.90-1.15],0.780135041889323
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,24,1.00 [0.91-1.09],0.96894275419657
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,24,0.97 [0.87-1.07],0.558278949375298
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,Inverse variance weighted,24,1.01 [0.90-1.13],0.892064632251753
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,24,1.12 [0.99-1.27],0.0818213829990587
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,24,1.01 [0.98-1.04],0.462289346494368
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,24,0.91 [0.83-0.99],0.0283870905332846
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,24,1.07 [0.93-1.23],0.351884457183054
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,24,0.94 [0.87-1.02],0.154722430710322
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,24,1.06 [1.01-1.12],0.0194952642281553
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,24,1.00 [0.91-1.10],0.991079108952616
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,24,1.00 [0.93-1.07],0.952866090263972
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,24,1.00 [0.93-1.07],0.968231311272875
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,24,1.09 [0.78-1.52],0.604383620824945
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,24,1.06 [0.90-1.25],0.472594641967686
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,24,0.82 [0.70-0.95],0.010956294203787
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,DVT of lower extremities,Inverse variance weighted,24,0.99 [0.93-1.07],0.880751778359991
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),Inverse variance weighted,24,0.98 [0.91-1.06],0.682602670013675
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,24,1.19 [0.97-1.46],0.103077780952041
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Venous thromboembolism,Inverse variance weighted,24,1.00 [0.95-1.06],0.930630552229367
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,24,1.04 [1.00-1.08],0.0378639292957468
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,24,1.05 [1.00-1.11],0.0666903968634309
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,24,1.10 [0.98-1.23],0.107675731499756
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,24,1.04 [0.95-1.15],0.390688138730306
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,24,0.78 [0.66-0.92],0.0027381370039648
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,24,1.02 [0.97-1.07],0.42840873476483
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,24,0.98 [0.94-1.02],0.347427435307604
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,24,0.95 [0.84-1.08],0.424951052349588
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,24,1.08 [0.96-1.23],0.207187016051125
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,24,1.00 [0.95-1.05],0.94375881965668
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,24,1.06 [0.97-1.16],0.22406047456296
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,Inverse variance weighted,24,1.05 [1.02-1.08],0.0003313918938375
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,24,1.11 [1.01-1.22],0.0278933201698931
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,24,1.14 [0.92-1.42],0.2390735869677
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,24,1.10 [0.95-1.27],0.210919440824044
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,24,1.31 [1.04-1.66],0.0243474413181375
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,24,1.12 [0.95-1.32],0.173950357211417
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,24,1.07 [0.94-1.22],0.28218096069431
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,24,1.05 [1.00-1.10],0.0410765332088601
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,24,1.08 [0.91-1.29],0.382188821517141
